Derma Sciences closes $80m deal for BioD
Derma Sciences (NSDQ:DSCI) said yesterday that it closed its acquisition of regenerative allograft maker BioD in a deal worth up to $78 million, including milestones and earn-outs. Princeton,...
View ArticleDetails emerge on Apple’s new health wearable
New details on the new health wearable Apple (NSDQ:AAPL) is said to be developing emerged yesterday when the U.S. Patent & Trademark Office released a patent application for a wrist- or ankle-worn...
View ArticleFractyl touts 1st-in-human data, grabs ex-GI Dynamics medical chief Maggs
Fractyl Laboratories today touted the publication of 1st-in-human data from a trial of its Revita duodenal mucosal resurfacing device and said it picked up former GI Dynamics (ASX:GID) medical chief...
View ArticleDutch coating supplier’s recall gives Cook Medical another headache
A Dutch supplier’s recall led to another headache for Cook Medical, already scrambling to recover from a massive catheter recall, when it prompted a partial recall of a wire guide used during...
View ArticleBonesupport wins FDA nod for Cerament G trial
Bonesupport said it won an investigational device exemption for the Fortify clinical trial of its next-generation Cerament G injectable antibiotic-eluting bone substitute. Cerament G product is an...
View ArticleSeno Medical grabs ex-CeloNova CFO Davis | Personnel Moves August 12, 2016
Seno Medical grabs ex-CeloNova CFO Davis Seno Medical Instuments said this week it tapped former CeloNova BioSciences chief financial officer Eric Davis to take over the CFO role at Seno Medical. Prior...
View ArticlePursuit Vascular raises $2.1m
Pursuit Vascular has raised $2.1 million in a new round of debt financing, according to an SEC filing posted today. Maple Grove, Minn.-based Pursuit Vascular produces the ClearGueard HD end caps for...
View ArticleMassDevice.com +5 | The top 5 medtech stories for August 12, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleLantheus deals Australian radiopharmacy supply biz to GMS
Lantheus Medical Imaging (NSDQ:LNTH) said yesterday it is selling its Australian radiopharmacy servicing business to Global Medical Solutions. As part of the deal, Lantheus and GMS entered into a...
View ArticleTAVR: Study shows benefit of Claret Medical’s Sentinel cerebral protection...
A study released this week reported that the use of Claret Medical‘s cerebral protection device during transcatheter aortic valve implantation procedures in patients with severe aortic stenosis can...
View ArticleTexas Medical Centers adds 11 medtech startups to incubator
The Texas Medical Center Innovation Institute on Wednesday announced the addition of 11 startups specifically focused on medical devices, a 1st for the incubator, as part of its TMCx program. As part...
View ArticleMaking continuous improvements in the combination products program: The...
By: Thinh Nguyen and Rachel E. Sherman, M.D., M.P.H. One question that sponsors often ask FDA is whether their medical product will be regulated as a drug, a device, a biologic, or as a combination...
View ArticleMazor X unveiling triggers another $20m from Medtronic
Mazor Robotics (NSDQ:MZOR) said today that the unveiling last month of its Mazor X robot-assisted spine surgery platform triggered the 2nd step in a 3-stage equity deal with Medtronic (NYSE:MDT)....
View ArticleJury signals deadlock in ex-banker’s insider trading trial
The jury deliberating over insider trading charges, leveled at an investment banker based on a quintet of medical device and life science acquisitions, reportedly told a federal judge last week that...
View ArticleFDA approves Intuity Elite rapid valve from Edwards Lifesciences
The FDA approved the Intuity Elite rapid deployment replacement aortic valve made by Edwards Lifesciences (NYSE:EW). Irvine, Calif.-based Edwards said the Intuity Elite valve is designed to create more...
View ArticleZimmer Biomet acquires CD Diagnostics
Zimmer Biomet (NYSE:ZBH) said today that it paid an unspecified amount to acquire CD Diagnostics and its line of immunoassay and biomarker products. Four years ago, the duo inked a pact that led to the...
View ArticleNN Precision Engineered Products Group certifies additive manufacturing...
NN Precision Engineered Products Group (PEP), a global manufacturer of highly engineered precision customized solutions serving the medical market, announced it has completed the validation and...
View ArticleKKR, TPG, Goldman close near $1b sales of Zimmer Biomet
Kohlberg Kravis Roberts & Co., TPG Global and Goldman Sachs said last week they closed the sale of nearly $1 billion worth of Zimmer Biomet (NYSE:ZBH) shares. The groups sold a total of 7.4 million...
View ArticleFDA approves BioSense Webster’s Thermocool SmartTouch catheter
Johnson & Johnson (NYSE:JNJ) subsidiary Biosense Webster said today it won FDA premarket approval for its Thermocool SmartTouch SF catheter designed for ablation procedures. The Diamond Bar,...
View ArticleMassDevice.com +5 | The top 5 medtech stories for August 15, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article